Skip to content

Artiste Mv SA

by Siemens Medical Solutions USA, Inc.

510(k) K072485

Artiste Mv SA is a Class II device made by Siemens Medical Solutions USA, Inc., cleared under FDA 510(k) K072485 on 27 Dec 2007, active as of 22 Oct 2026. 24 FDA recalls are linked to it.

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None ongoing

24 closed

Documents

Trust

Unverified

Source FDA 510(k), synced 22 Oct 2026.

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK072485 Date27 Dec 2007ClearedStatusActive

Official records

Recalls

24 recalls · FDA

    • Terminated Z-1677-2020 FDA Class II initiated 18 Feb 2020

    Potential safety issue with the dose monitoring system safety interlocks which could result in a 10-20% overdose of radiation therapy.

    • Terminated Z-1204-2019 FDA Class II initiated 20 Mar 2019

    Advisory issued not to disable or bypass the AMP function. Disabling or bypassing the AMP function for reasons of comfort is not advisable may lead to patient or user injury due to collision with LINAC equipment disabling the Auto Field Sequence (AFS) Automatic Motion Protection (AMP) function implemented at the control of the Digital Linear Accelerator.

    • Terminated Z-1488-2017 FDA Class II initiated 14 Feb 2017

    Software update

    • Terminated Z-1212-2017 FDA Class II initiated 25 Jan 2017

    Siemens became aware of Incorrect values for the rotational collimator position displayed due to mechanical problems of the sensor slide. In addition, there are improper weld seam at the overhead suspension.

    • Terminated Z-1059-2015 FDA Class II initiated 19 Dec 2014

    A hardware update to replace the old PCB Assembly, Head Driver-G41 with PCB with overcurrent protection as a result of reports of the electric board inside the gantry showing signs of overheating, including thermal damage and smoke emission.

    • Terminated Z-0980-2015 FDA Class II initiated 2 Dec 2014

    Use of any unauthorized third-party components on Siemens LINACs may lead to patient or operator injury, damage to the LINAC, and can potentially compromise customer warranty. The dark current dose must be considered in the overall dose calculation, or an overdose and serious injury may occur.

    • Terminated Z-2180-2014 FDA Class II initiated 17 Jun 2014

    Siemens became aware of a potential issue with the syngo RT Therapist 4.3.SP1 and syngo RT Oncologist 4.3SP1 software applications running on Siemens brand LINAC systems that may experience sporadic system crashes that will cause the inability to unload patient data.

    • Terminated Z-2174-2014 FDA Class II initiated 28 May 2014

    A safety risk exists with automatically sequenced treatment technique using the SIMTEC Auto Field Option where automatic movements of the gantry and the tabletop during an auto-sequenced treatment have the potential to lead to a collision with the patient.

    • Terminated Z-1645-2014 FDA Class II initiated 1 Apr 2014

    Table may lose calibration during patient treatment, which may cause the possibility of mistreatment.

    • Terminated Z-1652-2014 FDA Class II initiated 1 Apr 2014

    Siemens Radiation Oncology became aware that customers may be using the Siemens Linear Accelerator in combination with stereotactic accessories which have not been validated as being compatible with Siemens LINAC models.

    • Terminated Z-0438-2014 FDA Class II initiated 23 Oct 2013

    A safety risk regarding a potentially existing dark current radiation phenomenon on the Linear Accelerator (LINAC) in combination with IMRT or mARC (rotational IMRT) treatments using unflat (flattening filter free) beams. In case there are many long periods of field shape changes in a treatment plan, the dose due to dark current radiation may sum up to a significant value.

    • Terminated Z-1092-2012 FDA Not yet classified initiated 22 Jan 2012

    Software upgrade to installed base to the latest release of the RT Therapist version 4.1.144 which corrects multiple safety issues that could lead to patient mistreatment.

    • Terminated Z-3003-2011 FDA Unclassified (pre-2012) initiated 3 Jun 2011

    A potential safety issue was discovered when a pause for an imaging segment is inserted (where an imaging segment does not exist) with the ARTISTE and RT Therapist 4.1 system will continue to the next image.

    • Terminated Z-1422-2011 FDA Unclassified (pre-2012) initiated 3 Dec 2010

    The firm become aware of a potential issue with ARTISTE system that may result in patient injury should the positioner belt break, and the cam disc (secondary safety mechanism) is not installed and if the flat panel is over the patient.

    • Terminated Z-1523-2011 FDA Unclassified (pre-2012) initiated 29 Jun 2010

    A software problem that has the potential for data loss during the transfer of treatment records to the OIS, which may not be recorded in MOSAIQ, and subsequently may lead to mistreatment.

    • Terminated Z-0449-2011 FDA Unclassified (pre-2012) initiated 22 Jan 2010

    The robotic lift armature shaft may break and allow the Flat Panel Positioner with the digital flat panel imager to fall into the Flat Panel cradle. If the positioner is over a patient, there is a potential for injury.

    • Terminated Z-0121-2010 FDA Unclassified (pre-2012) initiated 10 Sep 2009

    A failed data transfer is possible that may result in data not being recorded in the interfaced system. Siemens Medical Solutions, Inc. USA became aware of this potential issue with its ARTISTE Linear Accelerator's Syngo RT Therapist v4.1 Workspace (containing the Siemens brand of Verify and Record application called PRIMEVIEW) and the LANTIS Oncology Information System product.

    • Terminated Z-1970-2011 FDA Unclassified (pre-2012) initiated 21 Aug 2009

    When editing the note type of a previously entered note, then reverting to the original type, data may be lost.

    • Terminated Z-1064-2011 FDA Unclassified (pre-2012) initiated 30 Jul 2009

    Potential for Mistreatment-- when treatment plans intended for non-ARTISTE machinese are loaded, if the plans contain unspecified beam parameters, attributes or unknown block codes, the therapy system may remove those parameters.

    • Terminated Z-1888-2009 FDA Unclassified (pre-2012) initiated 9 Apr 2009

    Unexpected treatment plan alteration-- Software issue may result in unintended modifications to treatment

    • Terminated Z-0949-2009 FDA Unclassified (pre-2012) initiated 20 Dec 2008

    The range of tolerance is to high for the accessory holder, therefore, Wedges and other accessories do not latch to the locking mechanism correctly.

    • Terminated Z-0857-2009 FDA Unclassified (pre-2012) initiated 23 Oct 2008

    Under certain conditions, the flat panel may move unexpectedly and collide with the patient.

    • Terminated Z-0927-2009 FDA Unclassified (pre-2012) initiated 23 Oct 2008

    If a plan contains a sequence of beams, including at least 1 ARC treatment beam and if during the setup stage of a beam following an ARC beam in the delivery sequence a termination occurs, and the user selects the immediate resumption feature, syngo RT Therapist Express systems will display and record a second delivery of a prior beam and not the delivery of the current beam in certain circumstanc

    • Terminated Z-0116-2009 FDA Unclassified (pre-2012) initiated 4 Jul 2008

    Three issues: unexpected rotation of gantry, unexpected movement of table between beams during patient setup, and single exposure images will be overwritten by double exposure images.

Timeline

25 dated events

  1. Recall initiated FDA recalls Z-1645-2014
  2. Recall initiated FDA recalls Z-1652-2014
  3. Recall initiated FDA recalls Z-2174-2014
  4. Recall initiated FDA recalls Z-2180-2014
  5. Recall initiated FDA recalls Z-0980-2015
  6. Recall initiated FDA recalls Z-1059-2015
  7. Recall initiated FDA recalls Z-1212-2017
  8. Recall initiated FDA recalls Z-1488-2017
  9. Recall initiated FDA recalls Z-1204-2019
  10. Recall initiated FDA recalls Z-1677-2020

15 earlier events are in the sections above.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA product code
IYE
Device class
Class II
Regulation
21 CFR Part 892.5050
Advisory committee
Radiology
FDA decision
SESE Substantially Equivalent

Similar devices

Other devices filed under FDA product code IYE (Accelerator, Linear, Medical).

Other devices from Siemens Medical Solutions USA, Inc.

See all devices from Siemens Medical Solutions USA, Inc. →